4//SEC Filing
French Anna Louise 4
Accession 0001213900-23-029901
CIK 0001788028other
Filed
Apr 13, 8:00 PM ET
Accepted
Apr 14, 4:19 PM ET
Size
4.9 KB
Accession
0001213900-23-029901
Insider Transaction Report
Form 4
French Anna Louise
Director
Transactions
- Sale
Voting Common Stock
2023-04-14$1.48/sh−7,000$10,360→ 23,750 total
Footnotes (1)
- [F1]These shares were sold by the Reporting Person solely in order to satisfy certain tax obligations in connection with the issuance of shares of the Issuer's common stock upon the vesting of restricted stock units.
Documents
Issuer
Jasper Therapeutics, Inc.
CIK 0001788028
Entity typeother
Related Parties
1- filerCIK 0001871871
Filing Metadata
- Form type
- 4
- Filed
- Apr 13, 8:00 PM ET
- Accepted
- Apr 14, 4:19 PM ET
- Size
- 4.9 KB